GlassScriptPhysician profile
David M Gent
NPI 1205818069
$15,170.62
in general payments reported to CMS, 2019-2025
18 companies · $2,387 in 2025
The $2,387 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,199 · 2020: $1,777 · 2021: $4,767 · 2022: $1,071 · 2023: $1,566 · 2024: $1,403 · 2025: $2,387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,062 · Food and Beverage: $2,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,061.57 |
| Food and Beverage | $2,295.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $6,608.40 | 2020-2025 | |
| Musculoskeletal Transplant Foundation INC. | $4,655.03 | 2019-2023 | |
| Arthrosurface Incorporated | $1,000.89 | 2019 | |
| Integra Lifesciences Corporation | $697.11 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paragon 28, INC. | $694.71 | 2021-2025 | Bun-Yo-Matic, Phantom Metatarsal Shortening, Portfolio |
| Organogenesis INC. | $328.70 | 2023-2025 | Affinity, Novachor, Puraply |
| Smith+Nephew, INC. | $299.63 | 2020-2025 | Renasys Touch, Grafix Pl, Renasys Go V2 Home |
| Zimmer Biomet Holdings, INC. | $219.26 | 2019-2025 | Nextremity General Instrument |
| Nevro Corp. | $149.69 | 2022-2024 | Senza |
| Invictus Surgical Incorporated | $118.38 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $117.94 | 2025 | |
| Fusion Orthopedics USA, LLC | $96.51 | 2025 | |
| Zyla Life Sciences, INC. | $86.04 | 2019-2020 | |
| Orthofix Medical, INC. | $38.73 | 2022-2025 | Physio-Stim |
| Paratek Pharmaceuticals, INC. | $20.66 | 2025 | Nuzyra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $14.52 | 2020 | |
| Djo, LLC | $13.51 | 2025 | Dr Comfort |
| Grt US Holding, INC. | $10.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.